Mealey's Patents

  • September 28, 2023

    Centripetal Files Brief In Appeal Of Adverse Review Of Threat Detection Patent

    WASHINGTON, D.C. — Citing a malfunctioning electronic court filing (ECF) website, Centripetal Networks LLC has asked the Federal Circuit U.S. Court of Appeals to excuse its filing of an appellant brief less than an hour after its deadline to do so in a dispute over a threat detection patent.

  • September 26, 2023

    Biotech Company Says MRNA Detection Patent Should Be Canceled

    ALEXANDRIA, Va. — The maker of the molecular profiling “Visium” system says in a Sept. 25 petition for inter partes review (IPR) that a patent directed to the spatial detection of oligonucleotides, such as mRNAs, in samples of tissue by using spatially barcoded arrays was anticipated by prior art.

  • September 26, 2023

    Panel Won’t Wade Into Disqualification Row Over Patent Licensing Testimony

    WASHINGTON, D.C. — A bid for mandamus was denied Sept. 25 by the Federal Circuit U.S. Court of Appeals, leaving in place a ruling by an administrative law judge (ALJ) for the International Trade Commission (ITC) that bars the testimony of an attorney at an upcoming evidentiary hearing on whether a patent owner can satisfy the domestic industry requirement.

  • September 26, 2023

    Claim Constructions By Texas Federal Judge Upheld By Federal Circuit

    WASHINGTON, D.C. — A stipulation that one patent directed to a mobile communication terminal with an alarm clock and another directed to an autofocus feature in a camera are both invalid will stand, the Federal Circuit U.S. Court of Appeals said Sept. 25.

  • September 25, 2023

    Panel:  Patent Settlement With Microsoft Dooms Later Infringement Claims

    WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals found Sept. 22 that a provision in a 2017 settlement between a patent owner and Microsoft Corp. reaches an allegedly infringing software program and website.

  • September 25, 2023

    RELX Defends Patent Ineligibility Holding In Brief To Federal Circuit

    WASHINGTON, D.C. — A patent was correctly declared by a federal judge in New York to be directed to the abstract idea of “timekeeping for compensation,” and its implementation on a computer is not enough to transform the idea into a patent eligible application, RELX Inc., doing business as LexisNexis, maintains in an appellee brief filed with the Federal Circuit U.S. Court of Appeals.

  • September 21, 2023

    Federal Circuit:  Clotting Factor Patent Not Sufficiently Enabled

    WASHINGTON, D.C. — In its second ruling in the case, the Federal Circuit U.S. Court of Appeals on Sept. 20 affirmed findings by a fellow member of its own court, sitting by designation in a federal court in Delaware, that a patent allegedly infringed by the hemophilia drug Hemlibra is invalid for lack of enablement.

  • September 20, 2023

    Patent Board:  Change In Inventors Has ‘No Impact’ On Final Written Decisions

    ALEXANDRIA, Va. — In a Sept. 19 ruling on remand from the Federal Circuit U.S. Court of Appeals, the Patent Trial and Appeal Board said that a correction of inventorship executed while the patent owner appealed two adverse final written decisions (FWDs) has no bearing on the FWDs.

  • September 20, 2023

    Texas Federal Magistrate Judge: Meta Owes Patent Owner $138,004 In Costs

    AUSTIN, Texas — A patent owner is entitled to recoup $138,004 in deposition and copying costs from Meta Platforms Inc., a federal magistrate judge in Texas has found nearly one year after a jury awarded $174,530,785 in connection with infringement by the “Facebook Live” feature.

  • September 19, 2023

    New York Federal Judge: RPI Has Standing In Patent Row With Amazon

    SYRACUSE, N.Y. — A bid by Amazon.com Inc. for dismissal of allegations that it infringes a patent owned by Rensselaer Polytechnic Institute (RPI) has failed, with a federal judge in New York concluding that the school and a licensee of the technology have standing to pursue their claims.

  • September 18, 2023

    Government Urges High Court To Uphold ‘Bedrock Principle’ Of Chevron Deference

    WASHINGTON, D.C. — The U.S. secretary of Commerce, two National Oceanic and Atmospheric Administration (NOAA) officials and the National Marine Fisheries Service (NMFS) (collectively, the government) urge the U.S. Supreme Court in a Sept. 15 brief to not overrule the doctrine of Chevron deference in a challenge to fishery regulations that were upheld by the District of Columbia Circuit U.S. Court of Appeals, writing that doing so could “cause disruption” to complex federal regulatory schemes.

  • September 18, 2023

    Panel Articulates Standard For Comparison Prior Art In Design Patent Disputes

    WASHINGTON, D.C. — Four years after vacating a summary judgment of infringement in a dispute over a patented heat reflecting material, the Federal Circuit U.S. Court of Appeals on Sept. 15 vacated a jury’s verdict, on remand, of noninfringement in the same dispute.

  • September 18, 2023

    Wal-Mart Prevails In Challenge Of Ceiling Light Retrofit Patent

    ALEXANDRIA, Va. — The Patent Trial and Appeal Board on Sept. 15 agreed with Wal-Mart Inc. that various claims of a patented kit that allows for the installation of a light emitting diode (LED) ceiling light in place of a previously installed fluorescent light fixture should be canceled.

  • September 15, 2023

    Panel Confirms Patentability Of E-Cigarette Technology In Blow To Philip Morris

    WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals ruled Sept. 15 that substantial evidence supports a final written decision by the Patent Trial and Appeal Board that rejected Philip Morris Products S.A.’s assertions that a patented e-cigarette would have been obvious to a person of skill in the art (POSITA).

  • September 15, 2023

    Claim Added In Coverage Dispute Over Loss Of Patent Litigation Counsel

    NASHVILLE, Tenn. — Mostly granting two motions, a Tennessee federal magistrate judge on Sept. 14 implemented the parties’ proposed schedule in a coverage dispute over loss of patent litigation counsel, also allowing the plaintiffs to add allegations and a promissory estoppel claim.

  • September 13, 2023

    After Review Denied, Patent Challenger Seeks PTO Director Intervention

    ALEXANDRIA, Va. — Citing the “rare” nature of a “split decision” by the Patent Trial and Appeal Board, which denied institution of inter partes review (IPR) of a patented system for “cashing out” of a wager before an event has ended, the petitioner requested review by the director of the U.S. Patent and Trademark Office.

  • September 12, 2023

    Panel Delivers Apple A Win, Reinstates Review Of Camera Lens Patent

    WASHINGTON, D.C. — The Patent Trial and Appeal Board must revisit its determinations in two final written decisions that Apple Inc. failed to establish that various challenged claims of a camera lens patent are obvious, the Federal Circuit U.S. Court of Appeals ruled Sept. 11.

  • September 11, 2023

    Board Correctly Declared Solar Cell Assembly Patent Obvious, Petitioner Says

    WASHINGTON, D.C. — A successful inter partes review petitioner maintains in a new appellee brief filed with the Federal Circuit U.S. Court of Appeals that an appellant brief by the patent owner “wrongly attempts to transform” a final written decision (FWD) by the Patent Trial and Appeal Board “into something it is not.”

  • September 11, 2023

    Appellants Say Substitute Claims Wrongly Allowed By Patent Board

    WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals has been asked by a group of appellants in the telecommunications industry to reverse and remand the Patent Trial and Appeal Board’s determination that various substitute claims in a patented system and apparatus relating to “handshaking” in a cellular network are not anticipated or rendered obvious by the same prior art that invalidated the original claims.

  • September 11, 2023

    Patent Dispute Over ‘Tamper Resistant’ Tablets To Proceed In Delaware

    WILMINGTON, Del. — A bid by Accord Healthcare Inc. for judgment on the pleadings on allegations that its abbreviated new drug application (ANDA) infringes two patents directed to technology for producing “tamper resistant” tablets failed Sept. 8 when a judge from the Federal Circuit U.S. Court of Appeals, sitting by designation in the District of Delaware, denied the request.

  • September 08, 2023

    Anti-‘Pestware’ Patent Should Be Canceled, Trend Micro Tells Board

    ALEXANDRIA, Va. — In a Sept. 7 petition for inter partes review (IPR), Trend Micro Inc. says that a patented system and method for detecting pestware would have been obvious to a person of skill in the art, requiring cancellation of 15 patent claims.

  • September 07, 2023

    Patent Owner Bid To Undo Cancellation Of Claims Fails On Appeal

    WASHINGTON, D.C. — Substantial evidence supports an August 2019 final written decision by the Patent Trial and Appeal Board that 10 claims of a patented antenna system are anticipated or would be rendered obvious by prior art, the Federal Circuit U.S. Court of Appeals ruled Sept. 6.

  • September 07, 2023

    Palo Alto Networks Again Takes Aim At Rival’s Patent In New Petition

    ALEXANDRIA, Va. — A method of filtering data transfers that prevents “exfiltration” would have been obvious to a person of skill in the art, Palo Alto Networks Inc. maintains in its latest petition for inter partes review (IPR) of a patent it previously challenged unsuccessfully.

  • September 06, 2023

    Panel Says Immediate Review Of Venue Ruling In Patent Row Unwarranted

    WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals on Sept. 5 refused to weigh in on a Texas federal judge’s denial of a motion to dismiss a patent infringement action for improper venue.

  • September 05, 2023

    Board Construction Of Disputed Patent Claim Upheld On Appeal

    WASHINGTON, D.C. — “Connection rejection message” as the term is used in two mobile communications patents was properly construed by the Patent Trial and Appeal Board to mean “a message that rejects a connection,” the Federal Circuit U.S. Court of Appeals ruled Sept. 1, affirming that the technology is anticipated or rendered obvious by prior art.

Can't find the article you're looking for? Click here to search the Mealey's Patents archive.